Simmons & Simmons

Intellectual property.

Michael specialises in all types of transactions involving intellectual property. In addition to negotiating agreements, Michael often advises on contractual interpretation and disputes. This includes consortium agreements, joint ventures, licensing, commercialization agreements and financings, as well as share and asset deals. He has particular expertise in multi-party collaborations and funds involving industry, academia, technology transfer offices and governments. He has considerable experience in a wide range of industry sectors, including life sciences, technology, energy, financial institutions and consumer goods.

Michael also specialises in regulatory compliance, advising on matters such as interactions with healthcare professionals, clinical trials, marketing authorization, manufacturing, distribution, promotion and pharmacovigilance, as well as data privacy and regulatory data exclusivity. Michael is head of our firm’s UK life sciences practice.

Qualified 2002; partner 2012; secondment to GlaxoSmithKline and Castrol. He is the author of numerous articles and has spoken at conferences on a variety of topical intellectual property and regulatory issues, including recently on M&A considerations in licensing deals, borderline products, personalised medicines, clinical trials and social media.

Degree in genetics; Diploma in IP Law and Practice 2003.